Cytek Biosciences Stock Discussion

$Cytek Biosciences (CTKB.US)$
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
On May 28, 2024, Cytek Biosciences (Nasdaq: CTKB) announced that its 1-laser and 2-laser 6-color TBNK reagent cocktails received approval from China's National Medical Products Administration (NMPA) for clinical use. These reagents, used in the Cytek Northern Lights-Clinical (NL-CLC) cell analysis systems, aid in diagnosing and monitoring immune-related conditions...

$Cytek Biosciences (CTKB.US)$
NEWS
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
Cytek Biosciences has introduced the Enhanced Small Particle (ESP™) Detection Option for its Cytek Aurora™ and Cytek Northern Lights™ systems. This upgrade allows researchers to detect subcellular particles, such as extracellular vesicles (EVs), with superior sensitivity and resolution. The global EV market is projected to grow significantly, from $227.5...

Gapping up
In reaction to earnings/guidance:
• $PDD Holdings (PDD.US)$ +15% (The company said its performance was boosted by a recovery in consumer sentiment.)
Other news:
• $Hill International (HIL.US)$ +20% (Hill International and GISI announce enhancements to their strategic merger agreement)
• $FiscalNote Holdings (NOTE.US)$ +11.3% (files for 87,504,863 share common stock offering, relates to warrants)
• $Cytek Biosciences (CTKB.US)$ +2.9% (fi...

$Cytek Biosciences (CTKB.US)$ what's the word?